GlassScriptPhysician profile
Wei-Te Li
NPI 1639558745
$1,011.27
in general payments reported to CMS, 2019-2025
7 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $539 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944 · Education: $67.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.70 |
| Education | $67.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $355.79 | 2024-2025 | |
| Fujifilm Healthcare Americas Corporation | $204.53 | 2024 | Utaswako Afp-L3 |
| Boston Scientific Corporation | $169.59 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Medtronic, INC. | $114.04 | 2024-2025 | Signia |
| Baxter Healthcare | $72.26 | 2025 | |
| Veloxis Pharmaceuticals, INC. | $67.57 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.49 | 2024 | Livtencity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei-Te Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.